THE WORLD’S FIRST HYBRID CLOSED LOOP SYSTEM
MINIMED® 670G SYSTEM
The first and only system that constantly self-adjusts to automatically keep your sugar levels in range, based on how you live your everyday life.
Indicated for type 1 patients, 14 and over. WARNING: may not be safe for use in children under 7 or in those requiring less than 8 units of insulin per day.
The MiniMed 670G system with SmartGuard® HCL technology offers two new levels of personalization:
• The Suspend before low option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts.
• The Auto Mode option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night.
• Guardian® sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing.
Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter.
WHAT ARE OTHERS SAYING ABOUT
THE MINIMED® 670G SYSTEM?
JDRF
“A life-changing breakthrough.”
“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,”
TIME
One of the best 25 innovations
CBS
“A groundbreaking new device could change the lives of millions of people living with diabetes.”
De första 1000 patienterna i USA har nu börjat använda 670G
När blir den CE märkt i Europa?
När kommer den till Sveriger?
Nyhetsinfo
www red DiabetologNytt
